Gotta love Senator Rand Paul for his unrelenting focus on corruption regarding public health, especially the collusion between Dr. Fauci and varied entities.
One such entity includes Big Pharma, who Fauci appears all too eager to shill for, despite the obvious risks of rushed vaccines.
Which is why Paul recently demanded answers from Moderna CEO Stéphane Bancel, specifically with regards to the increased risks of myocarditis from the COVID vaccine
“Is there a higher interest or a higher incidence of myocarditis among adolescent males 16 to 24 after taking your vaccine?” Paul demanded.
Bancel gave a response typical of the dishonest White House press secretary, much to Paul’s chagrin.
“The data from the CDC actually have shown that there’s less myocarditis for people who get the vaccine versus who get COVID infection,” Bancel sniffed.
Way to not answer the question, Bancel. Paul asked specifically about a higher risk for carditis after taking the vaccine, not to compare myocarditis rates for individuals who contract COVID, especially as adolescents did not contract the illness as others did.
Moreover, Bancel was inaccurate in his facts anyway, which Paul pointed out.
“That is not true. And I’d like to enter into the record six peer-reviewed papers from the Journal of Vaccine, the Annals of Medicine that say the complete opposite of what you say,” Paul replied crisply.
And that’s when a real curveball was hurled: The fact that Paul was sitting on the real facts all along.
“I spoke with your president just last week, and he readily acknowledged, in private, that, yes, there is an increased risk of myocarditis. The fact that you can’t say it in public is quite disturbing,” Paul declared.
Incredibly disturbing, especially as Big Pharma got even richer from mandated vaccines.
At that point, it isn’t even free market economics anymore when the government dictates one must obtain a shot; it is almost as though profits are guaranteed for Big Pharma.
And what collusion that can be.
As reported by Fierce Pharma, Moderna has made an absolute killing, along with others, in various “royalty” agreements with varied public health entities in the United States.
“In Moderna’s earnings release Thursday, the company said it recently paid the National Institute of Allergy and Infectious Diseases (NIAID) a $400 million ‘catch-up payment’ under a new royalty-bearing license agreement between the parties. The payment is part of a license agreement between Moderna and NIAID inked late last year …
Going forward, Moderna agreed to pay NIAID “low single-digit royalties” on COVID-19 vaccine sales,” the outlet announced.
Well, how about that.
Something has clearly incentivized mandated vaccines, and it is not exactly a simple public health precaution.
Author: Ofelia Thornton